Contribution: Industrial Research Assistance Program – Contributions to Firms
Pegasus Biotech Incorporated
$349,715.00
BPE Plasmid Scale Up
FY 2024-25 · 2024-04-01
Summary
The BPE technology is a novel, DNA plasmid backbone/production method that is ultra-low-cost, and has superior transfection efficiency. The technology has been demonstrated at lab scale (1.0 L fermentation), and needs to be scaled up to a commercially viable pilot scale to aid commercialization, and support projects to market the technology. This project ultimately scales up the process to 20-30 L fermentation along with associated downstream processes.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Charlottetown|Charlottetown, Prince Edward Island, Canada
Recipient Type
For-profit organization
Business Number
760829879
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-04-01 | 2024-25 | $99,715.00 |
| 1 | 2024-04-01 | 2024-25 | $199,715.00 |
| 3 | 2024-04-01 | 2024-25 | $349,715.00 |
As published
Additional Information
This agreement has been amended 2 time(s). The total amended value is 150,000 dollars.
Additional Information (French)
Cet accord a été modifié 2 fois La valeur totale des modifications est de 150 000 dollars.
Agreement End Date
2025-05-26
Agreement Number
1016236
Agreement Start Date
2024-04-01
Agreement Title
BPE Plasmid Scale Up
Agreement Title (French)
Mise à l’échelle des plasmides BPE
Agreement Type
Contribution
Agreement Value
$349,715.00
Amendment Date
2025-01-24
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The BPE technology is a novel, DNA plasmid backbone/production method that is ultra-low-cost, and has superior transfection efficiency. The technology has been demonstrated at lab scale (1.0 L fermentation), and needs to be scaled up to a commercially viable pilot scale to aid commercialization, and support projects to market the technology. This project ultimately scales up the process to 20-30 L fermentation along with associated downstream processes.
Description (French)
La technologie BPE est une nouvelle méthode de production et de support de plasmide ADN à très faible coût et d’une efficacité de transfection supérieure. La technologie a été démontrée à l’échelle du laboratoire (fermentation de 1,0 L) et doit être portée à une échelle pilote commercialement viable pour faciliter la commercialisation et soutenir les projets de mise sur le marché de la technologie. Ce projet vise à faire passer le processus à une échelle de fermentation de 20 à 30 litres, ainsi qu’aux processus en aval associés.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
760829879
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
Pegasus Biotech Incorporated
Recipient Postal Code
C1A 4P3
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2023-2024-Q4-1016236
